Provision Of New Cardiomyocyte Progenitor Cells And Cardiomyocytes Derived Therefrom

Patent No. EP2126052 (titled "Provision Of New Cardiomyocyte Progenitor Cells And Cardiomyocytes Derived Therefrom") was filed by Lead Pharma CEL Models on Jan 9, 2008. The application was issued on Dec 10, 2014.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JAMES POOLESep 10, 2015GOODFELLOW

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2126052

LEAD PHARMA CEL MODELS
Application Number
EP08706977A
Filing Date
Jan 9, 2008
Status
Revoked
Publication Date
Dec 10, 2014